Al Delbany D, Ghosh M, Krivec N, Huyghebaert A, Regin M, Duong M
Cells. 2024; 13(16).
PMID: 39195283
PMC: 11353044.
DOI: 10.3390/cells13161395.
Lei Y, Al Delbany D, Krivec N, Regin M, Couvreu de Deckersberg E, Janssens C
Stem Cell Reports. 2024; 19(4):562-578.
PMID: 38552632
PMC: 11096619.
DOI: 10.1016/j.stemcr.2024.03.001.
Yanagihara K, Hayashi Y, Liu Y, Yamaguchi T, Hemmi Y, Kokunugi M
In Vitro Cell Dev Biol Anim. 2024; 60(5):521-534.
PMID: 38169039
PMC: 11126453.
DOI: 10.1007/s11626-023-00824-9.
Ludwig T, Andrews P, Barbaric I, Benvenisty N, Bhattacharyya A, Crook J
Stem Cell Reports. 2023; 18(9):1744-1752.
PMID: 37703820
PMC: 10545481.
DOI: 10.1016/j.stemcr.2023.08.003.
Vitillo L, Anjum F, Hewitt Z, Stavish D, Laing O, Baker D
Stem Cell Reports. 2023; 18(3):782-797.
PMID: 36801002
PMC: 10031278.
DOI: 10.1016/j.stemcr.2023.01.007.
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies.
Cichocki F, van der Stegen S, Miller J
Blood. 2022; 141(8):846-855.
PMID: 36327161
PMC: 10023718.
DOI: 10.1182/blood.2022016205.
Standardization of Cell Culture Conditions and Routine Genomic Screening under a Quality Management System Leads to Reduced Genomic Instability in hPSCs.
Molina-Ruiz F, Introna C, Bombau G, Galofre M, Canals J
Cells. 2022; 11(13).
PMID: 35805069
PMC: 9265327.
DOI: 10.3390/cells11131984.
The Tumorigenic Potential of Human Pluripotent Stem Cells.
Lezmi E, Benvenisty N
Stem Cells Transl Med. 2022; 11(8):791-796.
PMID: 35679163
PMC: 9397652.
DOI: 10.1093/stcltm/szac039.
The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.
Keller A, Spits C
Cells. 2021; 10(11).
PMID: 34831467
PMC: 8625075.
DOI: 10.3390/cells10113246.
Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition.
Price C, Stavish D, Gokhale P, Stevenson B, Sargeant S, Lacey J
Dev Cell. 2021; 56(17):2455-2470.e10.
PMID: 34407428
PMC: 8443275.
DOI: 10.1016/j.devcel.2021.07.019.
Aneuploidy as a promoter and suppressor of malignant growth.
Vasudevan A, Schukken K, Sausville E, Girish V, Adebambo O, Sheltzer J
Nat Rev Cancer. 2021; 21(2):89-103.
PMID: 33432169
DOI: 10.1038/s41568-020-00321-1.
Acquired genetic changes in human pluripotent stem cells: origins and consequences.
Halliwell J, Barbaric I, Andrews P
Nat Rev Mol Cell Biol. 2020; 21(12):715-728.
PMID: 32968234
DOI: 10.1038/s41580-020-00292-z.
Nucleosides Rescue Replication-Mediated Genome Instability of Human Pluripotent Stem Cells.
Halliwell J, Frith T, Laing O, Price C, Bower O, Stavish D
Stem Cell Reports. 2020; 14(6):1009-1017.
PMID: 32413278
PMC: 7355123.
DOI: 10.1016/j.stemcr.2020.04.004.
Low rates of mutation in clinical grade human pluripotent stem cells under different culture conditions.
Thompson O, von Meyenn F, Hewitt Z, Alexander J, Wood A, Weightman R
Nat Commun. 2020; 11(1):1528.
PMID: 32251294
PMC: 7089967.
DOI: 10.1038/s41467-020-15271-3.
Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival.
Zhang J, Hirst A, Duan F, Qiu H, Huang R, Ji Y
Stem Cell Reports. 2019; 12(3):557-571.
PMID: 30773485
PMC: 6411485.
DOI: 10.1016/j.stemcr.2019.01.013.
Simplified Footprint-Free Cas9/CRISPR Editing of Cardiac-Associated Genes in Human Pluripotent Stem Cells.
Kondrashov A, Duc Hoang M, Smith J, Bhagwan J, Duncan G, Mosqueira D
Stem Cells Dev. 2018; 27(6):391-404.
PMID: 29402189
PMC: 5882176.
DOI: 10.1089/scd.2017.0268.
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.
Andrews P, Ben-David U, Benvenisty N, Coffey P, Eggan K, Knowles B
Stem Cell Reports. 2017; 9(1):1-4.
PMID: 28700896
PMC: 7206225.
DOI: 10.1016/j.stemcr.2017.05.029.
Detecting Genetic Mosaicism in Cultures of Human Pluripotent Stem Cells.
Baker D, Hirst A, Gokhale P, Juarez M, Williams S, Wheeler M
Stem Cell Reports. 2016; 7(5):998-1012.
PMID: 27829140
PMC: 5106530.
DOI: 10.1016/j.stemcr.2016.10.003.
Parametric analysis of colony morphology of non-labelled live human pluripotent stem cells for cell quality control.
Kato R, Matsumoto M, Sasaki H, Joto R, Okada M, Ikeda Y
Sci Rep. 2016; 6:34009.
PMID: 27667091
PMC: 5036041.
DOI: 10.1038/srep34009.
White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies.
Burns A, Goldstein A, Newgreen D, Stamp L, Schafer K, Metzger M
Dev Biol. 2016; 417(2):229-51.
PMID: 27059883
PMC: 5026875.
DOI: 10.1016/j.ydbio.2016.04.001.